Innovative Transdermal Patch for Delivery of HIV Medicine

October 25th, 2011 admin Posted in Announcements, Medical Research No Comments »

An innovative delivery method for human immunodeficiency virus (HIV) medications has been developed through use of a transdermal patch, the first of its kind to treat HIV. This research is being presented at the 2011 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in Washington, D.C., Oct. 23-27.

Read the rest of this entry »

Share/Save/Bookmark

AddThis Social Bookmark Button

Biologists Develop a Machine To Remove Viruses From Blood

August 20th, 2009 admin Posted in Medical Research No Comments »

A machine designed by infectious disease experts that works much like a dialysis machine called Hemopurifier. In hemopurifier, thin fibers are used to capture and remove viruses from the blood it filters. The machine requires the drawing of blood through an artery, which is sent through a tube into the machine, then back into the body. It can treat a number of illnesses.

Share/Save/Bookmark

AddThis Social Bookmark Button

Viral Safety of Plasma-derived Blood Products.

August 4th, 2009 admin Posted in Medical Research No Comments »

Viral Safety of Plasma-derived Blood Products. III. Effects of Virus Inactivation by Pasteurization in Human Serum Albumin Concentrates (Sekijyuji Albumin and Sekijyuji Albumin 25).

The Japanese scientists recently investigated the Effects of virus inactivation by      Pasteurization in Human Serum Albumin Concentrates ( Sekijyuji Albumin and Sekijyuji Albumin 25).These protein products were heat treated at 60.DEG.C. in liquid-phase(pasteurization) using several enveloped and non-enveloped viruses as marker viruses. Enveloped viruses were sindbis virus (SIN), vesicular stomatitis virus(VSV), herpes simplex virus type-1(HSV-1) and human immunodeficiency virus type-1(HIV-1). Non-enveloped viruses were polio virus (Polio V) and hepatitis A virus(HAV). The infectivity of all viruses except HAV was lost after 1hr heating, with logarithmic reduction value(LRV) for SIN,VSV,HSV-1,HIV-1 and Polio V of >5.1,>5.7,>4.3,>3.8 and >5.9, respectively. No significant difference in LRVs were observed between the two products. The infectivity of HAV, however, remained at 104.2-5.0TCID50 even after 10hr heating and LRV stayed in the range of 1.9 to 2.7

Share/Save/Bookmark

AddThis Social Bookmark Button